NORTH AMERICA AND EUROPE MINIMALLY INVASIVE PROSTATE CANCER SURGERY MARKET ANALYSIS

North America And Europe Minimally Invasive Prostate Cancer Surgery Market, By Product Type (Hand (Resectoscope, Linear Cutter, Insufflators, Curved Stapler, Endoscopic Trocars, Prostatic Retractor, Cryoablation Device, Others), Monitoring & Visualization (Cameras & Video Support, Endoscopic Trocars with Optical View), Powered (Electrosurgical Unit, Lasers)), By Application (Laparoscopy, Robotics, Brachytherapy, Cryosurgery), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers) and by Region (North America, and Europe)

North America and Europe Minimally Invasive Prostate Cancer Surgery Market: Key Developments

On January 31, 2023, Prostate Cancer Foundation (PCF), world’s leading philanthropic organization is dedicated to fund life-saving prostate research, announced the 2022 Class of PCF Team Challenge Award recipients and US $12 million funding for innovative prostate cancer research
Increasing inorganic strategies, such as collaborations, funding’s, and investments among key market players, are expected to propel the growth of the North America and Europe minimally invasive prostate cancer surgery market. For instance, in May 2021, University of California, San Francisco (UCSF) in collaboration with San Francisco Veteran Affairs (VA) Health Care System, the Prostate Cancer Foundation, a philanthropic organization, launched the Drew Foundation Precision Oncology Center of Excellence, providing precision medicine treatment to veterans facing prostate cancer.

North America And Europe Minimally Invasive Prostate Cancer Surgery Market Report Snapshots